1990至2017年慢性呼吸系统疾病的患病率与归因健康负担:GBD 2017系统分析
该研究基于GBD 2017数据,分析1990至2017年全球慢性呼吸系统疾病(哮喘、慢阻肺、间质性肺病与肺结节病、尘肺等)的患病率、死亡与DALY负担。归因于人口老龄化与增长,年龄标化患病率、死亡率与DALY率均下降。
核心结论
- 慢性呼吸系统疾病仍是全球死亡和残疾的主要原因,绝对数量增长但多项年龄标化指标自1990年以来大幅下降。
- 人均卫生资源较少地区的慢性呼吸系统疾病过早死亡似乎最高。
研究设计与样本
- 基于GBD 2017数据的系统分析,按GBD超级区域、年龄和性别分层,估计1990至2017年慢性呼吸系统疾病的患病率、死亡、DALY和YLL。
- 分析疾病包括哮喘、慢阻肺、间质性肺病与肺结节病、尘肺及其他慢性呼吸系统疾病。
- 评估吸烟、二手烟、环境颗粒物与臭氧污染、固体燃料家庭空气污染及职业风险对慢性呼吸系统疾病归因DALY的贡献。
主要发现
- 男性和女性中,大多数慢性呼吸系统疾病归因死亡和DALY由慢阻肺导致。
- 南亚慢性呼吸系统疾病死亡率最高、撒哈拉以南非洲最低;南亚YLL为全球最高。
关键数值与推荐
- 男性各区域首位风险因素为吸烟;女性南亚和撒哈拉以南非洲首位风险因素为固体燃料家庭空气污染。
临床怎么用
- 应重视慢性呼吸系统疾病的全球疾病负担,尤其关注慢阻肺导致的死亡和DALY。
- 在南亚等卫生资源较少地区,需针对慢性呼吸系统疾病过早死亡加强防控。
- 男性控烟与女性固体燃料家庭空气污染干预是降低归因负担的关键方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma. In this study, we aimed to characterise the burden of chronic respiratory diseases globally, providing a comprehensive and up-to-date analysis on geographical and time trends from 1990 to 2017. METHODS: Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, we estimated the prevalence, morbidity, and mortality attributable to chronic respiratory diseases through an analysis of deaths, disability-adjusted life-years (DALYs), and years of life lost (YLL) by GBD super-region, from 1990 to 2017, stratified by age and sex. Specific diseases analysed included asthma, COPD, interstitial lung disease and pulmonary sarcoidosis, pneumoconiosis, and other chronic respiratory diseases. We also assessed the contribution of risk factors (smoking, second-hand smoke, ambient particulate matter and ozone pollution, household air pollution from solid fuels, and occupational risks) to chronic respiratory disease-attributable DALYs. FINDINGS: In 2017, 544·9 million people (95% uncertainty interval [UI] 506·9-584·8) worldwide had a chronic respiratory disease, representing an increase of 39·8% compared with 1990. Chronic respiratory disease prevalence showed wide variability across GBD super-regions, with the highest prevalence among both males and females in high-income regions, and the lowest prevalence in sub-Saharan Africa and south Asia. The age-sex-specific prevalence of each chronic respiratory disease in 2017 was also highly variable geographically. Chronic respiratory diseases were the third leading cause of death in 2017 (7·0% [95% UI 6·8-7·2] of all deaths), behind cardiovascular diseases and neoplasms. Deaths due to chronic respiratory diseases numbered 3 914 196 (95% UI 3 790 578-4 044 819) in 2017, an increase of 18·0% since 1990, while total DALYs increased by 13·3%. However, when accounting for ageing and population growth, declines were observed in age-standardised prevalence (14·3% decrease), age-standardised death rates (42·6%), and age-standardised DALY rates (38·2%). In males and females, most chronic respiratory disease-attributable deaths and DALYs were due to COPD. In regional analyses, mortality rates from chronic respiratory diseases were greatest in south Asia and lowest in sub-Saharan Africa, also across both sexes. Notably, although absolute prevalence was lower in south Asia than in most other super-regions, YLLs due to chronic respiratory diseases across the subcontinent were the highest in the world. Death rates due to interstitial lung disease and pulmonary sarcoidosis were greater than those due to pneumoconiosis in all super-regions. Smoking was the leading risk factor for chronic respiratory disease-related disability across all regions for men. Among women, household air pollution from solid fuels was the predominant risk factor for chronic respiratory diseases in south Asia and sub-Saharan Africa, while ambient particulate matter represented the leading risk factor in southeast Asia, east Asia, and Oceania, and in the Middle East and north Africa super-region. INTERPRETATION: Our study shows that chronic respiratory diseases remain a leading cause of death and disability worldwide, with growth in absolute numbers but sharp declines in several age-standardised estimators since 1990. Premature mortality from chronic respiratory diseases seems to be highest in regions with less-resourced health systems on a per-capita basis. FUNDING: Bill & Melinda Gates Foundation.
引用
- Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020. PMID: 32526187. doi:10.1016/S2213-2600(20)30105-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。